Total Raised

$31.3M

Investors Count

8

Deal Terms

1

Holmusk Funding, Holmusk Valuation & Holmusk Revenue

6 Fundings

Holmusk's latest funding round was a Series B for on December 6, 2021.

Holmusk's valuation in September 2018 was $30M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/6/2021

Series B

0

FY undefined

1

5/18/2020

Series A

$99M

0

FY undefined

10

5/25/2019

Incubator/Accelerator - II

0

FY undefined

10

4/18/2019

Incubator/Accelerator

$99M

0

FY undefined

10

9/25/2018

Seed VC

$99M

$30M

0

FY undefined

10

Date

12/6/2021

5/18/2020

5/25/2019

4/18/2019

9/25/2018

Round

Series B

Series A

Incubator/Accelerator - II

Incubator/Accelerator

Seed VC

Amount

$99M

$99M

$99M

Investors

Valuation

$30M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

Holmusk Deal Terms

1 Deal Term

Holmusk's deal structure is available for 1 funding round, including their Seed VC from September 25, 2018.

Round

Seed VC

Funding Date

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Seed VC

$99M

$99M

$99M

$99M

$99M

$99M

Holmusk Investors

8 Investors

Holmusk has 8 investors. Heritas Capital invested in Holmusk's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/25/2018

12/6/2021

3
Seed VC, Series A (2020), Series B (2021)

Venture Capital

Singapore

00/00/0000

00/00/0000

Health Catalyst Capital Management

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Optum Ventures

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

dRx Capital

Subscribe to see more

Venture Capital

Switzerland

00/00/0000

00/00/0000

Northwell Holdings & Ventures

Subscribe to see more

Corporate Venture

New York

First funding

9/25/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/6/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Health Catalyst Capital Management

Optum Ventures

dRx Capital

Northwell Holdings & Ventures

Rounds

3
Seed VC, Series A (2020), Series B (2021)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Corporate Venture

Venture Capital

Corporate Venture

Location

Singapore

New York

California

Switzerland

New York

Holmusk Acquisitions

1 Acquisition

Holmusk acquired 1 company. Their latest acquisition was Otsuka Health Solutions on April 27, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/27/2021

Other

$99M

Acquired

2

Date

4/27/2021

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

2

You May Also Like

Virta Health Logo
Virta Health

Virta Health develops a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery.

Vida Health Logo
Vida Health

Vida Health is a virtual care company that combines a human-centric approach with technology to address chronic physical and behavioral health conditions. The company provides personalized digital therapeutic programs combined with real human health coaching & therapy through a mobile & online platform that supports individuals in managing & reversing conditions such as diabetes, hypertension, obesity, depression, anxiety, stress, asthma, & more. The platform integrates individual expert care with machine learning & remote monitoring to deliver lasting behavior change, health outcomes & cost savings.

Glooko Logo
Glooko

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

Canary Health Logo
Canary Health

Canary Health is a provider of digital health self-management programs which includes a CDC approved online diabetes prevention program and a chronic disease self-management program.

WellDoc Logo
WellDoc

WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.

Wellocity Health Logo
Wellocity Health

Wellocity Health is a digital therapeutics company that offers a telehealth platform to organizations for delivering evidence-based personalized lifestyle change programs focused on preventing diabetes and heart disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.